The equity award is structured under the firm's 2026 Inducement Plan, a mechanism reserved specifically for hiring individuals who were not previously employed by the San Diego-based diagnostics provider. According to company filings, the units carry a three-year vesting schedule, with equal annual installments contingent upon Young’s continued service at the company through each anniversary date.
In section Releases
QuidelOrtho Grants CFO Micah Young Equity Package
The Compensation Committee of QuidelOrtho Corporation has issued restricted stock units covering 356,555 shares of common stock to newly appointed Chief Financial Officer Micah Young. The grant serves as a material inducement for his entry into the company, finalized on July 15, 2026, under Nasdaq Listing Rule 5635(c)(4).
QuidelOrtho, which operates across clinical chemistry and molecular testing sectors, utilizes these grants to secure executive talent as part of its broader strategy to integrate diagnostic insights into healthcare decision-making. The award is governed by the specific terms of the 2026 Inducement Plan and an individual RSU agreement.
Comments (0)
No comments yet. Be the first!